4
MARKET OVERVIEW
Capitalize on emerging economies' untapped adhesion barrier markets amid global geriatric population surge.
43
4.2.1.1
RAPID GROWTH IN GERIATRIC POPULATION GLOBALLY
4.2.1.2
INCREASE IN VOLUME OF SURGERIES
4.2.1.3
INCREASING AWARENESS ABOUT MEDICAL IMPLICATIONS OF ADHESIONS
4.2.2.1
RELUCTANCE OF SURGEONS TO USE ADHESION BARRIERS
4.2.3.1
UNTAPPED MARKETS IN EMERGING ECONOMIES
4.2.3.2
GROWING NUMBER OF HOSPITALS
4.2.4.1
STRINGENT REGULATIONS AND LIMITED TECHNOLOGICAL INNOVATIONS
4.3
UNMET NEEDS AND WHITE SPACES
4.3.1
UNMET NEEDS IN ADHESION BARRIER MARKET
4.3.2
WHITE SPACE OPPORTUNITIES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1
INTERCONNECTED MARKET
4.4.2
CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate competitive dynamics and economic shifts shaping the biosurgery industry's future landscape.
53
5.1
PORTER'S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
INTENSITY OF COMPETITIVE RIVALRY
5.1.3
BARGAINING POWER OF BUYERS
5.1.4
BARGAINING POWER OF SUPPLIERS
5.1.5
THREAT OF SUBSTITUTES
5.2
MACROECONOMICS OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN BIOSURGERY INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.6.1
AVERAGE SELLING PRICE OF ADHESION BARRIER, BY PRODUCT
AVERAGE SELLING PRICE TREND OF ADHESION BARRIER, BY REGION,
5.7.1
IMPORT DATA FOR ADHESION BARRIER (HS CODE: 300610)
5.7.2
EXPORT DATA FOR ADHESION BARRIER (HS CODE: 300610)
5.8
KEY CONFERENCES & EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10.1
CASE STUDY 1: WORLD LAPAROSCOPY HOSPITAL DEMONSTRATES CLINICAL ADOPTION OF INTERCEED FOR POSTOPERATIVE ADHESION PREVENTION IN LAPAROSCOPIC SURGERY
5.10.2
CASE STUDY 2: BUDDHIST TZU CHI GENERAL HOSPITAL ACHIEVES HIGH SEPRAFILM PLACEMENT SUCCESS USING A MODIFIED LAPAROSCOPIC APPLICATION TECHNIQUE
5.10.3
CASE STUDY 3: FUKUSHIMA MEDICAL UNIVERSITY DEMONSTRATES SAFE AND RELIABLE LAPAROSCOPIC APPLICATION OF SEPRAFILM USING A REDUCER SLEEVE TECHNIQUE
5.11
IMPACT OF 2025 US TARIFFS ON ADHESION BARRIER MARKET
5.11.3
PRICE IMPACT ANALYSIS
5.11.5
IMPACT ON END-USE INDUSTRIES
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT,
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
HYDROGEL BIOMATERIALS
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.3.1
SHORT-TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION
6.3.2
MID-TERM (2027-2030) | EXPANSION & STANDARDIZATION
6.3.3
LONG-TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION
6.4.1
PATENT PUBLICATION TRENDS FOR ADHESION BARRIER MARKET
6.4.2
TOP APPLICANTS (COMPANIES) OF ADHESION BARRIER PATENTS
6.4.3
JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN ADHESION BARRIER MARKET
6.4.4
LIST OF MAJOR PATENTS
6.5
IMPACT OF AI/GEN AI ON ADHESION BARRIER MARKET
6.5.1
TOP USE CASES AND MARKET POTENTIAL
6.5.2
TOP CASE STUDIES OF AI IMPLEMENTATION IN ADHESION BARRIER MARKET
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN ADHESION
6.6
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
6.6.1
BAXTER: SEPRAFILM - EVIDENCE-BACKED ADHESION REDUCTION IN ABDOMINAL & PELVIC SURGERY
6.6.2
JOHNSON & JOHNSON MEDTECH/ETHICON: GYNECARE INTERCEED - STANDARDIZED ADHESION PREVENTION IN GYNECOLOGIC SURGERY
6.6.3
ANIKA THERAPEUTICS/HYALOBARRIER: HYALURONIC ACID GEL FOR LAPAROSCOPY, LAPAROTOMY & HYSTEROSCOPY
7
TREATMENT AND REGULATORY LANDSCAPE
Navigate complex global regulations with insights into regional compliance and medical device classifications.
82
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
CERTIFICATIONS, LABELLING, AND ECO-STANDARDS
CERTIFICATIONS, LABELLING, AND ECO-STANDARDS IN
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock profitability by navigating buyer dynamics, unmet needs, and stakeholder influence.
90
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2
KEY BUYING CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS IN END USERS
8.5.3
MARGIN OPPORTUNITIES IN KEY APPLICATIONS
9
ADHESION BARRIER MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Units | 12 Data Tables
95
9.2
SYNTHETIC ADHESION BARRIERS
9.2.1.1
GREATER BIOCOMPATIBILITY AND HIGHER BIORESORBABILITY TO DRIVE SEGMENT
9.2.2
REGENERATED CELLULOSE
9.2.2.1
NON-REACTIVE AND BACTERIOSTATIC NATURE OF REGENERATED CELLULOSE TO DRIVE USE IN GYNECOLOGICAL SURGERIES
9.2.3
POLYETHYLENE GLYCOL
9.2.3.1
ABILITY TO DECREASE POST-SURGICAL ADHESIONS AFTER ABDOMINAL AND PERITONEAL SURGERIES TO DRIVE SEGMENT
9.2.4
OTHER SYNTHETIC ADHESION BARRIERS
9.3
NATURAL ADHESION BARRIERS
9.3.1
TIME-CONSUMING AND COMPLEX APPLICATIONS DURING SURGERIES TO LIMIT MARKET
10
ADHESION BARRIER MARKET, BY FORMULATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 8 Data Tables
106
10.2.1
FILM FORMULATIONS DOMINATED ADHESION BARRIER MARKET IN 2025
10.3.1
HIGHER PREFERENCE FOR GEL-BASED FORMULATIONS OVER FILM-BASED BARRIERS TO DRIVE MARKET
LIQUID FORMULATIONS TO BE WIDELY USED IN GYNECOLOGICAL,
11
ADHESION BARRIER MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 11 Data Tables
113
11.2
GYNECOLOGICAL SURGERIES
11.2.1
RISING INCIDENCE OF PELVIC AND UTERINE CANCER AND INCREASING NUMBER OF C-SECTIONS TO DRIVE MARKET
11.3
GENERAL/ABDOMINAL SURGERIES
11.3.1
INCREASING FORMATION OF POST-OPERATIVE ADHESIONS AND RISING COMPLICATIONS AMONG PATIENTS TO DRIVE MARKET
11.4
CARDIOVASCULAR SURGERIES
11.4.1
HIGH NUMBER OF CONGENITAL HEART DISEASE PATIENTS TO DRIVE MARKET
11.5
ORTHOPEDIC SURGERIES
11.5.1
GROWING VOLUME OF ORTHOPEDIC PROCEDURES TO DRIVE MARKET
11.6
NEUROLOGICAL SURGERIES
11.6.1
GROWING CONCERNS ABOUT PHYSICAL PAIN AND IMPAIRMENT AFTER NEUROLOGICAL SURGERIES TO DRIVE MARKET
11.7
RECONSTRUCTIVE SURGERIES
11.7.1
HIGHER INSURANCE COVERAGE FOR COSMETIC SURGERIES TO DRIVE MARKET
11.8
UROLOGICAL SURGERIES
11.8.1
GROWING INCIDENCE OF POST-OPERATIVE ADHESION FORMATION TO DRIVE MARKET
12
ADHESION BARRIER MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 4 Data Tables
125
12.2
HOSPITALS AND CLINICS
12.2.1
INCREASING INVESTMENT IN HOSPITALS TO DRIVE MARKET
12.3
AMBULATORY SURGICAL CENTERS
12.3.1
INCREASING NUMBER OF OUTPATIENT VISITS AND FAVORABLE REIMBURSEMENT POLICIES TO DRIVE MARKET
13
ADHESION BARRIER MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 145 Data Tables.
130
13.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
13.2.2.1
US DOMINATED NORTH AMERICAN ADHESION BARRIER MARKET IN 2025
13.2.3.1
INCREASING NUMBER OF C-SECTION SURGERIES TO DRIVE MARKET
13.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
13.3.2.1
GROWTH IN HEALTHCARE SPENDING TO DRIVE MARKET
13.3.3.1
RISING NUMBER OF ADVANCED ORTHOPEDIC SURGERIES TO DRIVE MARKET
13.3.4.1
RISING NUMBER OF CARDIOVASCULAR, GYNECOLOGICAL, AND ORTHOPEDIC SURGERIES TO DRIVE MARKET
13.3.5.1
RISING GERIATRIC POPULATION AND INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
13.3.6.1
HIGH COST OF SURGICAL PROCEDURES TO LIMIT MARKET
13.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
13.4.2.1
RISING GERIATRIC POPULATION AND INCREASING NUMBER OF SURGICAL PROCEDURES PERFORMED TO DRIVE MARKET
13.4.3.1
GROWING NUMBER OF HOSPITALS AND HEALTHCARE POLICY REFORMS TO DRIVE GROWTH
13.4.4.1
RISING FOCUS OF MULTINATIONAL COMPANIES ON INDIAN MARKET AND IMPROVING URBAN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
13.4.5.1
GROWING GOVERNMENT AWARENESS CAMPAIGNS AND RISING FUNDING AND GRANTS FOR MEDICAL RESEARCH TO DRIVE MARKET
13.4.6.1
GROWING GERIATRIC POPULATION TO DRIVE MARKET
13.4.7
REST OF ASIA PACIFIC
13.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
13.5.2.1
WELL-ESTABLISHED HEALTHCARE SYSTEM TO DRIVE SUSTAINED GROWTH IN MARKET
13.5.3.1
RISING CHRONIC DISEASES AND WELL-ORGANIZED HEALTHCARE SYSTEM TO DRIVE MARKET
13.5.4
REST OF LATIN AMERICA
13.6
MIDDLE EAST & AFRICA
13.6.1
STRENGTHENING OF HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
13.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
13.6.4
REST OF MIDDLE EAST & AFRICA
14
COMPETITIVE LANDSCAPE
Discover key strategies and revenue shifts shaping the adhesion barrier market's competitive landscape.
200
14.2
KEY PLAYER STRATEGY/RIGHT TO WIN
14.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ADHESION BARRIER MARKET
14.3
REVENUE ANALYSIS, 2021–2025
14.4
MARKET SHARE ANALYSIS, 2025
14.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
14.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
14.5.5.1
COMPANY FOOTPRINT
14.5.5.2
REGION FOOTPRINT
14.5.5.3
PRODUCT FOOTPRINT
14.5.5.4
APPLICATION FOOTPRINT
14.5.5.5
FORMULATION FOOTPRINT
14.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
14.6.1
PROGRESSIVE COMPANIES
14.6.2
RESPONSIVE COMPANIES
14.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
14.7
BRAND/PRODUCT COMPARISON
14.8
COMPANY VALUATION AND FINANCIAL METRICS
14.9
COMPETITIVE SCENARIO
14.9.1
PRODUCT LAUNCHES AND APPROVALS
14.9.4
OTHER DEVELOPMENTS
15
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
218
15.1.1.1
BUSINESS OVERVIEW
15.1.1.2
PRODUCTS OFFERED
15.1.1.3
RECENT DEVELOPMENTS
15.1.1.3.1
OTHER DEVELOPMENTS
15.1.1.4.2
STRATEGIC CHOICES
15.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
15.1.3
INTEGRA LIFESCIENCES CORPORATION
15.1.4
TERUMO CORPORATION
15.1.6
ANIKA THERAPEUTICS INC.
15.1.11
BIOSCOMPASS, INC.
15.1.12
W.L. GORE & ASSOCIATES, INC.
15.1.14
HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD
15.1.15
BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD.
15.1.16
DALIM TISSEN CO., LTD.
15.2.2
PLANTTEC MEDICAL GMBH
15.2.4
SAMYANG BIOPHARM CORPORATION
15.2.6
PROVIEW-MBD BIOTECH CO., LTD
15.2.8
ALAFAIR BIOSCIENCES
15.2.9
SCIVISION BIOTECH INC.
16
RESEARCH METHODOLOGY
256
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
16.1.2.2
KEY INDUSTRY INSIGHTS
16.2
MARKET SIZE ESTIMATION
16.2.1
BOTTOM-UP APPROACH
16.2.3
BASE NUMBER ESTIMATION
16.2.3.1
SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
16.2.3.2
COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
16.2.3.3
DEMAND-SIDE ANALYSIS
16.3
MARKET FORECAST APPROACH
16.4
MARKET BREAKDOWN AND DATA TRIANGULATION
16.5
MARKET SHARE ESTIMATION
16.8
RESEARCH LIMITATIONS
16.8.1
SCOPE-RELATED LIMITATIONS
16.8.2
METHODOLOGY-RELATED LIMITATIONS
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3
CUSTOMIZATION OPTIONS
TABLE 1
STANDARD CURRENCY CONVERSION RATES
TABLE 2
GERIATRIC POPULATION GROWTH RATE, BY REGION, 2020–2050
TABLE 3
LIST OF COMMON SPECIALTIES AND PROCEDURES IN OLDER ADULTS
TABLE 4
US: PERCENTAGE INCREASE IN NUMBER OF SURGICAL PROCEDURES PERFORMED (2010 VS. 2020)
TABLE 5
PER CAPITA NATIONAL INCOME (USD)
TABLE 6
ADHESION BARRIER MARKET: IMPACT OF PORTER'S FIVE FORCES ANALYSIS
TABLE 7
GDP PERCENTAGE CHANGE, BY KEY COUNTRIES, 2021–2030
TABLE 8
ADHESION BARRIER MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 9
AVERAGE SELLING PRICE OF ADHESION BARRIER, BY PRODUCT, 2025
TABLE 10
AVERAGE SELLING PRICE TREND OF ADHESION BARRIER PRODUCTS, BY REGION, 2023–2025
TABLE 11
IMPORT DATA FOR ADHESION BARRIER (HS CODE: 300610), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 12
EXPORT DATA FOR ADHESION BARRIER (HS CODE: 300610), BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 13
ADHESION BARRIER MARKET: LIST OF KEY CONFERENCES & EVENTS, 2026–2027
TABLE 14
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 15
KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR ADHESIVE BARRIER PRODUCTS
TABLE 16
ADHESION BARRIER MARKET: LIST OF MAJOR PATENTS
TABLE 17
TOP USE CASES AND MARKET POTENTIAL
TABLE 18
ADHESION BARRIER MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
TABLE 19
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
TABLE 21
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25
CLASSIFICATION OF MEDICAL DEVICES BY US FDA
TABLE 26
NMPA MEDICAL DEVICE CLASSIFICATION
TABLE 27
CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN
TABLE 28
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS
TABLE 29
KEY BUYING CRITERIA FOR END USERS
TABLE 30
ADOPTION BARRIERS & INTERNAL CHALLENGES
TABLE 31
ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 32
KEY BRANDS OF SYNTHETIC ADHESION BARRIERS
TABLE 33
SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 34
SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35
SYNTHETIC ADHESION BARRIERS MARKET, BY REGION, 2024–2031 (MILLION UNITS)
TABLE 36
HYALURONIC ACID MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37
REGENERATED CELLULOSE MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 38
POLYETHYLENE GLYCOL MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39
OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40
LIST OF NATURAL ADHESION BARRIERS AVAILABLE
TABLE 41
NATURAL ADHESION BARRIERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42
NATURAL ADHESION BARRIERS MARKET, BY REGION, 2024–2031 (MILLION UNITS)
TABLE 43
ADOPTION OF DIFFERENT ADHESION BARRIER FORMULATIONS IN SURGERIES
TABLE 44
ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 45
INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH FILM FORMULATIONS
TABLE 46
ADHESION BARRIER MARKET FOR FILM FORMULATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
TABLE 47
INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH GEL FORMULATIONS
TABLE 48
ADHESION BARRIER MARKET FOR GEL FORMULATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION)
TABLE 49
INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH LIQUID FORMULATIONS
TABLE 50
ADHESION BARRIER MARKET FOR LIQUID FORMULATIONS, BY COUNTRY 2024–2031 (USD MILLION)
TABLE 51
ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 52
PREVALENCE OF INTRAUTERINE ADHESIONS ACROSS DIFFERENT GYNECOLOGICAL PROCEDURES (IN %)
TABLE 53
COUNTRIES WITH HIGHEST C-SECTION RATES (2022)
TABLE 54
ADHESION BARRIER MARKET FOR GYNECOLOGICAL SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55
ADHESION BARRIER MARKET FOR GENERAL/ABDOMINAL SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56
ADHESION BARRIER MARKET FOR CARDIOVASCULAR SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57
ADHESION BARRIER MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58
ADHESION BARRIER MARKET FOR NEUROLOGICAL SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59
ADHESION BARRIER MARKET FOR RECONSTRUCTIVE SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60
ADHESION BARRIER MARKET FOR UROLOGICAL SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61
ADHESION BARRIER MARKET FOR OTHER SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62
ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 63
ADHESION BARRIER MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64
ADHESION BARRIER MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65
ADHESION BARRIER MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 66
ADHESION BARRIER MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 67
US: CUMULATIVE PROCEDURAL VOLUME, 2012-2023 (N = 3,715,320)
TABLE 68
NORTH AMERICA: ADHESION BARRIER MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69
NORTH AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 70
NORTH AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 71
NORTH AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 72
NORTH AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 73
NORTH AMERICA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 74
US: MACROECONOMIC INDICATORS
TABLE 75
US: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 76
US: SYNTHETIC ADHESION BARRIER MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 77
US: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 78
US: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 79
US: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 80
CANADA: MACROECONOMIC INDICATORS
TABLE 81
CANADA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 82
CANADA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 83
CANADA: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 84
CANADA: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 85
CANADA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 86
EUROPEAN COUNTRIES WITH HIGHEST C-SECTION RATE (2021)
TABLE 87
EUROPE: ADHESION BARRIER MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 88
EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 89
EUROPE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 90
EUROPE: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 91
EUROPE: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 92
EUROPE: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 93
GERMANY: MACROECONOMIC INDICATORS
TABLE 94
GERMANY: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 95
GERMANY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 96
GERMANY: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 97
GERMANY: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 98
GERMANY: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 99
SURGICAL PROCEDURES PERFORMED IN FRANCE, 2021
TABLE 100
FRANCE: KEY MACROECONOMIC INDICATORS
TABLE 101
FRANCE: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 102
FRANCE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 103
FRANCE: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 104
FRANCE: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 105
FRANCE: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 106
UK: KEY MACROECONOMIC INDICATORS
TABLE 107
UK: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 108
UK: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 109
UK: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 110
UK: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 111
UK: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 112
ITALY: KEY MACROECONOMIC INDICATORS
TABLE 113
ITALY: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 114
ITALY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 115
ITALY: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 116
ITALY: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 117
ITALY: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 118
SURGICAL PROCEDURES PERFORMED IN SPAIN, 2021
TABLE 119
SPAIN: KEY MACROECONOMIC INDICATORS
TABLE 120
SPAIN: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 121
SPAIN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122
SPAIN: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 123
SPAIN: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 124
SPAIN: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 125
REST OF EUROPE: PERCENTAGE OF GDP ON HEALTHCARE EXPENDITURE, BY COUNTRY
TABLE 126
REST OF EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 127
REST OF EUROPE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 128
REST OF EUROPE: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 129
REST OF EUROPE: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 130
REST OF EUROPE: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 131
ASIA PACIFIC: ADHESION BARRIER MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 132
ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 133
ASIA PACIFIC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 134
ASIA PACIFIC: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 135
ASIA PACIFIC: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 136
ASIA PACIFIC: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 137
JAPAN: KEY MACROECONOMIC INDICATORS
TABLE 138
JAPAN: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 139
JAPAN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 140
JAPAN: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 141
JAPAN: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 142
JAPAN: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 143
CHINA: KEY MACROECONOMIC INDICATORS
TABLE 144
CHINA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 145
CHINA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146
CHINA: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 147
CHINA: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 148
CHINA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 149
INDIA: KEY MACROINDICATORS
TABLE 150
INDIA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 151
INDIA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 152
INDIA: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 153
INDIA: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 154
INDIA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 155
AUSTRALIA: KEY MACROINDICATORS
TABLE 156
AUSTRALIA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 157
AUSTRALIA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 158
AUSTRALIA: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 159
AUSTRALIA: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 160
AUSTRALIA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 161
SOUTH KOREA: KEY MACROINDICATORS
TABLE 162
SOUTH KOREA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 163
SOUTH KOREA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 164
SOUTH KOREA: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 165
SOUTH KOREA: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 166
SOUTH KOREA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 167
REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 168
REST OF ASIA PACIFIC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 169
REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 170
REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 171
REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 172
LATIN AMERICA: ADHESION BARRIER MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 173
LATIN AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 174
LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 175
LATIN AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 176
LATIN AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 177
LATIN AMERICA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 178
BRAZIL: KEY MACROINDICATORS
TABLE 179
BRAZIL: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 180
BRAZIL: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 181
BRAZIL: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 182
BRAZIL: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 183
BRAZIL: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 184
MEXICO: KEY MACROINDICATORS
TABLE 185
MEXICO: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 186
MEXICO: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187
MEXICO: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 188
MEXICO: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 189
MEXICO: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 190
REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 191
REST OF LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 192
REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 193
REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 194
REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 195
MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 196
MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 197
MIDDLE EAST & AFRICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198
MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 199
MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 200
MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 201
GCC COUNTRIES: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 202
GCC COUNTRIES: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 203
GCC COUNTRIES: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 204
GCC COUNTRIES: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 205
GCC COUNTRIES: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 206
REST OF MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 207
REST OF MIDDLE EAST & AFRICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208
REST OF MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION)
TABLE 209
REST OF MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
TABLE 210
REST OF MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 211
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ADHESION BARRIER MARKET
TABLE 212
ADHESION BARRIER MARKET: DEGREE OF COMPETITION
TABLE 213
ADHESIVE BARRIER MARKET: REGION FOOTPRINT
TABLE 214
ADHESIVE BARRIER MARKET: PRODUCT FOOTPRINT
TABLE 215
ADHESIVE BARRIER MARKET: APPLICATION FOOTPRINT
TABLE 216
ADHESIVE BARRIER MARKET: FORMULATION FOOTPRINT
TABLE 217
ADHESION BARRIER MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 218
ADHESION BARRIER MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
TABLE 219
ADHESIVE BARRIER MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022– MAY 2026
TABLE 220
ADHESIVE BARRIER MARKET: DEALS, JANUARY 2022–MAY 2026
TABLE 221
ADHESIVE BARRIER MARKET: EXPANSIONS, JANUARY 2022–MAY 2026
TABLE 222
ADHESIVE BARRIER MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026
TABLE 223
BAXTER: COMPANY OVERVIEW
TABLE 224
BAXTER: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026
TABLE 225
JOHNSON & JOHNSON: COMPANY OVERVIEW
TABLE 226
JOHNSON & JOHNSON: DEALS, JANUARY 2022–MAY 2026
TABLE 227
JOHNSON & JOHNSON: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026
TABLE 228
INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
TABLE 229
INTEGRA LIFESCIENCES CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026
TABLE 230
TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 231
TERUMO CORPORATION: DEALS, JANUARY 2022–MAY 2026
TABLE 232
TERUMO CORPORATION: EXPANSIONS, JANUARY 2022–MAY 2026
TABLE 233
TERUMO CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026
TABLE 234
FZIOMED, INC.: COMPANY OVERVIEW
TABLE 235
FZIOMED, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2026
TABLE 236
ANIKA THERAPEUTICS INC.: COMPANY OVERVIEW
TABLE 237
ANIKA THERAPEUTICS INC.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026
TABLE 238
MAST BIOSURGERY: COMPANY OVERVIEW
TABLE 239
BETATECH MEDICAL: COMPANY OVERVIEW
TABLE 240
DONGSUNG: COMPANY OVERVIEW
TABLE 241
BIOSCOMPASS, INC.: COMPANY OVERVIEW
TABLE 242
W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW
TABLE 243
ALLOSOURCE: COMPANY OVERVIEW
TABLE 244
HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD.: COMPANY OVERVIEW
TABLE 245
BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD.: COMPANY OVERVIEW
TABLE 246
DALIM TISSEN CO., LTD.: COMPANY OVERVIEW
TABLE 247
RISK ASSESSMENT: ADHESION BARRIER MARKET
FIGURE 1
KEY INSIGHTS & MARKET HIGHLIGHTS
FIGURE 2
ADHESION BARRIER MARKET, BY PRODUCT, 2026–2031
FIGURE 3
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ADHESION BARRIER MARKET
FIGURE 4
DISRUPTIVE TRENDS IMPACTING GROWTH OF ADHESION BARRIER MARKET
FIGURE 5
HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN ADHESION BARRIER MARKET, 2025
FIGURE 6
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 7
INCREASING VOLUME OF SURGERIES AND RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 9
FILM FORMULATION SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2025
FIGURE 10
INDIA TO REGISTER HIGHEST CAGR FROM 2026 TO 2031
FIGURE 11
DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
FIGURE 12
ADHESION BARRIER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 13
ADHESION BARRIER MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 14
ADHESION BARRIER MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 15
ADHESION BARRIER MARKET: VALUE CHAIN ANALYSIS
FIGURE 16
ADHESION BARRIER MARKET: ECOSYSTEM ANALYSIS
FIGURE 17
REVENUE SHIFTS & NEW REVENUE POCKETS IN ADHESION BARRIER MARKET
FIGURE 18
TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) IN ADHESION BARRIER (2015–2025)
FIGURE 19
JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR ADHESION BARRIER PATENTS, 2015–2025
FIGURE 20
CE APPROVAL PROCESS IN EUROPE FOR BIOSURGERY PRODUCTS
FIGURE 21
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS IN KEY END USERS
FIGURE 22
KEY BUYING CRITERIA FOR KEY END USERS
FIGURE 23
ADHESION BARRIER MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 24
NORTH AMERICA: ADHESION BARRIER MARKET SNAPSHOT
FIGURE 25
ASIA PACIFIC: ADHESION BARRIER MARKET SNAPSHOT
FIGURE 26
REVENUE ANALYSIS OF KEY PLAYERS IN ADHESION BARRIER MARKET (2021−2025)
FIGURE 27
MARKET SHARE ANALYSIS OF KEY PLAYERS IN ADHESION BARRIER MARKET (2025)
FIGURE 28
ADHESION BARRIER MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 29
ADHESIVE BARRIER MARKET: COMPANY FOOTPRINT
FIGURE 30
ADHESION BARRIER MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 31
ADHESION BARRIER MARKET: BRAND/PRODUCT COMPARISON
FIGURE 32
EV/EBITDA OF KEY VENDORS
FIGURE 33
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDOR
FIGURE 34
BAXTER: COMPANY SNAPSHOT (2025)
FIGURE 35
JOHNSON & JOHNSON: COMPANY SNAPSHOT (2025)
FIGURE 36
INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 37
TERUMO CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 38
ANIKA THERAPEUTICS INC.: COMPANY SNAPSHOT (2025)
FIGURE 39
DONGSUNG: COMPANY SNAPSHOT (2025)
FIGURE 40
RESEARCH DESIGN
FIGURE 41
PRIMARY SOURCES
FIGURE 42
BOTTOM-UP APPROACH
FIGURE 43
TOP-DOWN APPROACH
FIGURE 44
SUPPLY-SIDE ADHESION BARRIER MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 45
REVENUE SHARE ANALYSIS ILLUSTRATION: BAXTER INTERNATIONAL
FIGURE 46
SUPPLY-SIDE ANALYSIS: ADHESION BARRIER MARKET (2025)
FIGURE 47
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 48
DATA TRIANGULATION METHODOLOGY
Growth opportunities and latent adjacency in Adhesion Barrier Market